Kiniksa Pharmaceuticals, Ltd.
Kiniksa Pharmaceuticals, Ltd. (KNSA) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 455 transactions totaling $137.3M, demonstrating a bullish sentiment with $5.2M in net insider flow. The most recent transaction on Feb 4, 2026 involved a transaction of 2,602 shares valued at $0.
KNSA Insider Activity Summary
Who Is Buying KNSA Stock?
No significant insider buying has been recorded for KNSA in the recent period.
Who Is Selling KNSA Stock?
No significant insider selling has been recorded for KNSA in the recent period.
Is Kiniksa Pharmaceuticals, Ltd. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KNSA is bullish with an Insider Alignment Score of 52/100 and a net flow of $5.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
KNSA Frequently Asked Questions
Understanding KNSA Insider Activity
Insider trading at Kiniksa Pharmaceuticals, Ltd. (KNSA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading KNSA stock, having executed 455 transactions in the past 90 days. The most active insider is Brothers Life Sciences Lp Baker (Executive), who has made 5 transactions totaling $54.0M.
Related Tools
Track Kiniksa Pharmaceuticals, Ltd. Insider Activity
Get notified when executives and directors at KNSA file new Form 4 transactions